Literature DB >> 15760265

Endografting of the aortic arch.

Shin Ishimaru1.   

Abstract

In recent years, endovascular repair with stent-grafts has made great advances as a minimally invasive alternative to conventional open surgery in the treatment of aortic aneurysm and dissection. Although many commercial endograft systems are now used worldwide for the treatment of these pathologies in the abdominal aorta, only a few dedicated stent-grafts have been developed for use in the thoracic aorta. However, these second-generation commercial endografts have almost identical specifications and performance profiles in terms of structure, function, and delivery mechanism as stent-graft systems employed in the abdominal aorta. Thus, endografts have been used in the thoracic aorta with little consideration to the morphological and hemodynamic characteristics specific to the aortic arch and the deployment techniques needed to navigate this curved region of the thoracic aorta. This review will survey the literature on aortic arch stent-graft repair and identify key elements critical to the successful design of an endograft to treat lesions in the aortic arch.

Entities:  

Mesh:

Year:  2004        PMID: 15760265     DOI: 10.1583/04-1407.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  40 in total

1.  Unusual complications of endovascular repair of the thoracic aorta: MDCT findings.

Authors:  T Valente; G Rossi; F Lassandro; G Rea; M Marino; G Dialetto; R Muto; M Scaglione
Journal:  Radiol Med       Date:  2012-01-07       Impact factor: 3.469

2.  Outcomes of thoracic endovascular aortic repair using aortic arch chimney stents in high-risk patients.

Authors:  Igor Voskresensky; Salvatore T Scali; Robert J Feezor; Javairiah Fatima; Kristina A Giles; Rosamaria Tricarico; Scott A Berceli; Adam W Beck
Journal:  J Vasc Surg       Date:  2017-07       Impact factor: 4.268

3.  Ascending aorta measurements as assessed by ECG-gated multi-detector computed tomography: a pilot study to establish normative values for transcatheter therapies.

Authors:  Tri-Linh C Lu; Christoph H Huber; Elena Rizzo; Jashmid Dehmeshki; Ludwig K von Segesser; Salah D Qanadli
Journal:  Eur Radiol       Date:  2008-09-23       Impact factor: 5.315

Review 4.  Managing dissections of the thoracic aorta.

Authors:  Daniel R Wong; Scott A Lemaire; Joseph S Coselli
Journal:  Am Surg       Date:  2008-05       Impact factor: 0.688

5.  Tortuosity of the Descending Thoracic Aorta in Patients with Aneurysm and Type B Dissection.

Authors:  Viony M Belvroy; Hector W L de Beaufort; Joost A van Herwaarden; Jean Bismuth; Gabriele Piffaretti; Frans L Moll; Santi Trimarchi
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

6.  Early outcomes of extra-thoracic debranching thoracic endovascular aortic repair for distal aortic arch disease.

Authors:  Kazuya Kobayashi; Toshihiro Ohata; Hideki Ueda; Yoshihiko Kurimoto
Journal:  J Artif Organs       Date:  2014-06-11       Impact factor: 1.731

7.  Is total debranching a safe procedure for extensive aortic-arch disease? A single experience of 27 cases.

Authors:  Emanuele Ferrero; Michelangelo Ferri; Andrea Viazzo; Alessandro Robaldo; Edoardo Zingarelli; Fabrizio Sansone; Riccardo Casabona; Franco Nessi
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

Review 8.  Debranching aortic surgery.

Authors:  Manuel Alonso Pérez; José Manuel Llaneza Coto; José Antonio Del Castro Madrazo; Carlota Fernández Prendes; Mario González Gay; Amer Zanabili Al-Sibbai
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

9.  Endovascular total arch replacement techniques and early results.

Authors:  Vladimir Makaloski; Nikolaos Tsilimparis; Fiona Rohlffs; Franziska Heidemann; Eike Sebastian Debus; Tilo Kölbel
Journal:  Ann Cardiothorac Surg       Date:  2018-05

10.  Hybrid treatment of isolated aortic arch aneurysms.

Authors:  D Laganà; G Carrafiello; D Lumia; A Ianniello; F Fontana; M Mangini; P Castelli; C Fugazzola
Journal:  Radiol Med       Date:  2009-09-22       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.